These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9697885)
21. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma]. Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579 [No Abstract] [Full Text] [Related]
22. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226 [TBL] [Abstract][Full Text] [Related]
23. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure. Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225 [TBL] [Abstract][Full Text] [Related]
24. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21). Ha CS; Tucker SL; Lee MS; McLaughlin P; Cabanillas F; Cox JD Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):727-32. PubMed ID: 11172955 [TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab. Czuczman MS; Grillo-López AJ; Alkuzweny B; Weaver R; Larocca A; McLaughlin P Leuk Lymphoma; 2006 Sep; 47(9):1830-40. PubMed ID: 17064996 [TBL] [Abstract][Full Text] [Related]
26. Treatment and prognosis of centrocytic (mantle cell) lymphoma: a retrospective analysis of twenty-six patients treated in one institution. Zucca E; Fontana S; Roggero E; Pedrinis E; Pampallona S; Cavalli F Leuk Lymphoma; 1994 Mar; 13(1-2):105-10. PubMed ID: 8025512 [TBL] [Abstract][Full Text] [Related]
27. [The clinical characteristics of 681 patients with diffuse large B-cell lymphoma]. Wen JJ; Liu ZB; Xu J; Xu CG Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1004-9. PubMed ID: 23363791 [TBL] [Abstract][Full Text] [Related]
29. Clinical and prognostic analysis of 125 cases of non-Hodgkin's lymphoma. Liu L; Zhang M; Zou P Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):547-50. PubMed ID: 18549626 [TBL] [Abstract][Full Text] [Related]
30. Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders. Wong KF; Chan JK; So JC; Yu PH Cancer; 1999 Sep; 86(5):850-7. PubMed ID: 10463985 [TBL] [Abstract][Full Text] [Related]
31. Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index. Sarkozy C; Terré C; Jardin F; Radford I; Roche-Lestienne C; Penther D; Bastard C; Rigaudeau S; Pilorge S; Morschhauser F; Bouscary D; Delarue R; Farhat H; Rousselot P; Hermine O; Tilly H; Chevret S; Castaigne S Genes Chromosomes Cancer; 2014 Jan; 53(1):106-16. PubMed ID: 24249260 [TBL] [Abstract][Full Text] [Related]
32. [The clinical features, therapeutic effects and prognosis of mantle cell lymphoma]. Zhang HX; Xu J; Liu T; Xu CG Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):231-5. PubMed ID: 21569704 [TBL] [Abstract][Full Text] [Related]
33. Bone marrow and peripheral blood involvement in mantle cell lymphoma. Cohen PL; Kurtin PJ; Donovan KA; Hanson CA Br J Haematol; 1998 May; 101(2):302-10. PubMed ID: 9609526 [TBL] [Abstract][Full Text] [Related]
34. Mantle cell lymphoma in the ocular adnexal region. Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830 [TBL] [Abstract][Full Text] [Related]
35. The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma. Micallef IN; Remstein ED; Ansell SM; Colgan JP; Inwards DJ; Johnston PB; Lewis JT; Markovic SN; Porrata LF; White WL; Witzig TE; Ristow K; Habermann TM Leuk Lymphoma; 2006 Sep; 47(9):1794-9. PubMed ID: 17064990 [TBL] [Abstract][Full Text] [Related]
36. Reassessment of non-hodgkins's lymphoma with a "nodular" growth variant: a clinicopathologic study of follicular, mantle cell and marginal zone lymphomas prospectively diagnosed with multiparameter analyses. Kadowaki I; Ichinohasama R; Sasaki O; Kimura J; Kameoka JI; Meguro K; Endo K; Tobinai K; Sasaki T; Sawai T; Ooya K Leuk Lymphoma; 1998 Oct; 31(3-4):393-403. PubMed ID: 9869204 [TBL] [Abstract][Full Text] [Related]
37. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma. Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944 [TBL] [Abstract][Full Text] [Related]
38. Mantle cell lymphoma in the Chinese: clinicopathological features and treatment outcome. Chim CS; Chan AC; Choo CK; Kwong YL; Lie AK; Liang R Am J Hematol; 1998 Dec; 59(4):295-301. PubMed ID: 9840910 [TBL] [Abstract][Full Text] [Related]
39. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]